A Study of Galunisertib on the Immune System in Participants With Cancer
Clinical trial NCT02304419 · COMPLETED
Trial details
- NCT number
- NCT02304419
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-08-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.